2 completed, 1 not yet recruiting. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Not yet recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Clinical Trial: new trials by email Literature Review of Clinical Trial trials Research Report on Clinical Trial
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of iPSC-Derived Motor Neuron Cells (XS228) in Subacute Spinal Cord Injury: A Phase II Randomized Controlled Trial Allogeneic Human Induced Pluripotent Stem Cell (iPSC)-Derived Motor Neuron Progenitor Cells, Placebo - Spinal Cord Injury, Safety | Phase 2 | Not yet recruiting | XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. | 60 | 2028-05-25 | 2025-11-25 |
| Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection Chloroquine Diphosphate, Placebo oral tablet - COVID-19, SARS-CoV Infection | Phase 2 | Completed | Fundação de Medicina Tropical Dr. Heitor Vieira Dourado | 152 | 2020-04-08 | 2021-08-09 |
| Evaluation of Pharmacokinetics and Safety Tolerability of Higher Doses of Rifampic Evaluation of high dose rifampicin in children - Clinical Trial | Phase 1 / Phase 2 | Completed | Kilimanjaro Clinical Research Institute | 31 | 2019-07-01 | 2024-02-15 |
COVID-19 (1) · Pneumonia (1) · Severe Acute Respiratory Syndrome (1) · Spinal Cord Injuries (1) · Tuberculosis (1)
Infections (2) · Actinomycetales Infections (1) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Central Nervous System Diseases (1) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Gram-Positive Bacterial Infections (1) · Lung Diseases (1) · Mycobacterium Infections (1) · Nervous System Diseases (1) · Nidovirales Infections (1) · Pneumonia, Viral (1) · RNA Virus Infections (1) · Respiratory Tract Diseases (1)
Chloroquine (1) · Clinical Trials Data Monitoring Committees (1) · Rifampin (1) · chloroquine diphosphate (1)
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (1) · Kilimanjaro Clinical Research Institute (1) · XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. (1)
Brazil (1) · China (1) · Tanzania (1)